Condition: Invasive Fungal Infection · Sponsor: Merck Sharp & Dohme LLC
This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants \<2 years of age with invasive fungal infection (IFI).
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Rady Children's Hospital-San Diego ( Site 2101) | San Diego, California, United States | Completed |
| Nicklaus Children's Hospital ( Site 2109) | Miami, Florida, United States | Completed |
| Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 2104) | Chicago, Illinois, United States | Recruiting |
| Duke University Medical Center ( Site 2106) | Durham, North Carolina, United States | Completed |
| Driscoll Children's Hospital ( Site 2113) | Corpus Christi, Texas, United States | Completed |
| UCL Saint Luc ( Site 1050) | Brussels, Bruxelles-Capitale, Region de, Belgium | Recruiting |
| UZ Gent ( Site 1052) | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
| UZ Leuven ( Site 1051) | Leuven, Vlaams-Brabant, Belgium | Recruiting |
| Athens Childrens Hospital Aglaia Kyriakou ( Site 1102) | Athens, Attica, Greece | Completed |
| General Hospital of Thessaloniki "Ippokrateio" ( Site 1100) | Thessaloniki, Greece | Recruiting |
| Rambam Medical Center ( Site 1402) | Haifa, Israel | Recruiting |
| Hadassah Ein Karem Hebrew University Medical Center ( Site 1401) | Jerusalem, Israel | Completed |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04665037